| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 09/11/2009 | WO2004039952A3 Methods of use for novel human polypeptides encoded by polynucleotides |
| 09/10/2009 | US20090229008 Transcription factors |
| 09/10/2009 | US20090227504 Pegylated Factor VII Glycoforms |
| 09/09/2009 | EP1885848A4 Microbial conversion of sugar acids and means useful therein |
| 09/09/2009 | CN101525605A Araboxylan degrading enzyme |
| 09/09/2009 | CN100537764C Metabolic protein for weed-control agent, its gene, and its use |
| 09/08/2009 | US7585942 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule |
| 09/08/2009 | US7585657 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 09/03/2009 | WO2004092333A3 Methods of selection, reporting and analysis of genetic markers using broad based genetic profiling applications |
| 09/03/2009 | US20090220549 Reagents for recombinogenic engineering and use thereof |
| 09/02/2009 | CN101519449A Modified transferrin fusion proteins |
| 09/01/2009 | US7584059 Inhibition of immune complex formation |
| 09/01/2009 | US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 08/27/2009 | US20090217405 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 08/27/2009 | US20090214557 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/26/2009 | EP1624891B1 Clotting factor-fc chimeric proteins to treat hemophilia |
| 08/26/2009 | EP1461464A4 A method for identifying markers |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | CN101514356A Angiogensis models using nestin-expressing stem cells to image nascent blood vessels |
| 08/26/2009 | CN100532539C Product |
| 08/25/2009 | US7579515 Use of the present invention will enhance proper timing; if the switch increases ovulation >2.4-fold, oocyte production can be achieved even more efficiently, creating major benefits for the transgenic/cloning industry |
| 08/20/2009 | US20090208530 HIV polynucleotides and polypeptides derived from Botswana MJ4 |
| 08/20/2009 | US20090208477 Production of high mannose proteins in plant culture |
| 08/20/2009 | US20090208419 Multimodality Imaging of Reporter Gene Expression Using a Novel Fusion Vector in Living Cells and Animals |
| 08/18/2009 | US7575895 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/13/2009 | US20090203882 Novel microbial enzymes and their use |
| 08/13/2009 | US20090203588 Outcome prediction and risk classification in childhood leukemia |
| 08/13/2009 | US20090203143 Trans-splicing mediated photodynamic therapy |
| 08/13/2009 | US20090203128 Nogo-Receptors and Methods of Use |
| 08/13/2009 | US20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/12/2009 | EP1687323A4 Methods and compositions for seamless cloning of nucleic acid molecules |
| 08/11/2009 | US7572949 SKN-1 and GSK-3 genes and proteins |
| 08/11/2009 | US7572395 Organic species that facilitate charge transfer to or from nanostructures |
| 08/06/2009 | US20090199306 Fucosyl transferase gene |
| 08/06/2009 | US20090197307 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 08/05/2009 | CN100523215C RNA interference mediating small RNA molecules |
| 08/05/2009 | CN100522151C Compounds for treatment of inflammation, diabetes and related disorders |
| 08/04/2009 | US7569543 An extracellular matrix (ECM)-binding fragment of Angiopoietin-1 protein or a non-ECM binding fragment of Ang-1 protein that contains a modification in an ECM-binding domain of Ang-1, or a proteolytic resistant fragment of Ang-1 protein that contains a modification in a proteolytic domain of Ang-1 |
| 08/04/2009 | US7569385 Multipotent amniotic fetal stem cells |
| 08/04/2009 | US7569345 Prognosing survivability of patients with cell proliferative disorders based on tumor antigen gene expression profile; prognosing tumor recurrence |
| 08/04/2009 | US7569217 Porcine adenovirus E1 and E4 regions |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/29/2009 | EP1689430B1 Tyrosinase mutant and methods of use thereof |
| 07/29/2009 | EP1623044B1 Methods for amplification of nucleic acid sequences using staggered ligation |
| 07/29/2009 | CN100519751C Optimization of cell for endogenous gene activation |
| 07/23/2009 | WO2005056752A9 Methods and compositions for delivering polynucleotides |
| 07/23/2009 | WO2005042707A9 Taspasel 1 and methods of use |
| 07/23/2009 | US20090186843 RNA sequence-specific mediators of RNA interference |
| 07/23/2009 | US20090186765 Tubulin regulatory elements for use in plants |
| 07/23/2009 | US20090186397 Product |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/22/2009 | EP2080521A1 Gastrin compositions and formulations, and methods of use and preparation |
| 07/22/2009 | EP1651751A4 Engineered proteases for affinity purification and processing of fusion proteins |
| 07/22/2009 | CN101487012A Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 07/22/2009 | CN101486761A Human coagulation factor VII variants |
| 07/22/2009 | CN100516081C Motoneuronotrophic factor gene sequences |
| 07/21/2009 | US7563928 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/21/2009 | US7563600 For in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments |
| 07/21/2009 | US7563450 UL16 binding protein 4 |
| 07/16/2009 | US20090181034 Antibodies and related molecules that bind to psca proteins |
| 07/15/2009 | CN101481409A BASB027 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses |
| 07/15/2009 | CN100513560C Method for virus propagation |
| 07/14/2009 | US7560538 Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region |
| 07/14/2009 | US7560531 Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers |
| 07/14/2009 | US7560265 Compositions for regulation of tumor necrosis factor-alpha |
| 07/14/2009 | US7560230 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent |
| 07/14/2009 | US7560113 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 07/09/2009 | US20090176975 Methods and compositions for detecting promoter activity and expressing fusion proteins |
| 07/09/2009 | US20090175887 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 07/08/2009 | EP2077121A1 Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder |
| 07/02/2009 | US20090171077 Delivery of nucleic acid-like compounds |
| 07/02/2009 | US20090170799 Chimeric oligonucleotide for use in diagnosis and treatment of tissue destruction, necrosis and inflammatory diseases |
| 07/02/2009 | US20090169571 Selected ma motifs to include cell death and/or apoptosis |
| 07/01/2009 | EP2075340A2 Gene modulation by RB2/p 130 expression |
| 07/01/2009 | EP2075335A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/01/2009 | EP1684782A4 Process for the synchronization of ovulation for timed breeding without heat detection |
| 07/01/2009 | EP1666048A4 Method for producing insulin from a natural source and insulin |
| 07/01/2009 | CN100506841C Method and carrier complexes for delivering molecules to cells |
| 06/30/2009 | US7553647 Differental lysis and extraction of cell contents; DNA extraction and gene expression analysis; automatic |
| 06/30/2009 | US7553643 Comprises modified base such as 6-amino-3-prop-1-ynyl-5-hvdropyrazolo[3,4-d]pyrimidine-4-one |
| 06/30/2009 | US7553628 Production of polyunsaturated fatty acids in oleaginous yeasts |
| 06/25/2009 | US20090163844 Methods for the treatment or prevention of scars and/or keloids |
| 06/25/2009 | US20090162859 Compositions, methods and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals |
| 06/24/2009 | EP1565200A4 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | EP1303591B1 Masp-2, a complement-fixing enzyme, and uses for it |
| 06/23/2009 | US7550266 Methods and systems for dynamic gene expression profiling |
| 06/18/2009 | WO2004070002A3 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/18/2009 | WO2004046335A3 A method for cloning of a rare, specifically mutated cell |
| 06/18/2009 | US20090156790 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 06/18/2009 | US20090156502 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule |
| 06/18/2009 | US20090155282 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/17/2009 | EP1713900A4 Methods and systems for annotating biomolecular sequences |
| 06/16/2009 | US7547530 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 06/16/2009 | US7547522 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells |
| 06/16/2009 | US7547511 Antisense inhibition of laminin-8 expression to inhibit human gliomas |